Influence of GSTM1 genotypes on anti-BPDE-DNA adduct levels in mononuclear white blood cells of humans exposed to PAH

International Archives of Occupational and Environmental Health

Volumn 72, Issue 4, 1999, Pages 238-246

  Pavanello, S ^a   Gabbani, G ^a   Mastrangelo, G ^a   Brugnone, F ^b   Maccacaro, G ^b   Clonfero, E ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

Biomonitoring; BPDE DNA adducts; GSTM1 genotype; HPLC fluorescence; PAH exposure

Indexed keywords

7,8 DIHYDROXYBENZO[A]PYRENE 9,10 OXIDE; COKE;

ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DRUG DNA BINDING; FLUORESCENCE ANALYSIS; GENE DELETION; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; MULTIVARIATE ANALYSIS; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; URINARY EXCRETION;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ADOLESCENT; ADULT; CARCINOGENS; CHEMICAL INDUSTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA ADDUCTS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLYCYCLIC COMPOUNDS; POLYMORPHISM, GENETIC;

OXY;

EID: 0032780067     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004200050367     Document Type: Article

References (57)

1. Alexandrie AK, Sunderberg MI, Seidergard J, Tornling G, Ranung A (1994) Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 15: 1785-1790
2. Alexandrov K, Rojas M, Geneste O, Castegnaro M, Camus A-M, Petruzzelli S, Giuntini C, Bartsch H (1992) An improved fluorimetric assay for dosimetry of benzo[a]pyrene diolepoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res 51: 6248-6253
3. Binkova B, Lewtas J, Miskova I, Rössner P, Cernà M, Mràckova G, Peterkovà K, Mumford Y, Meyer S, Sram R (1996) Biomarker studies in Northern Bohemia. Environ Health Perspect 104 [Suppl 3]: 591-597
4. 32P-postlabelling. Mutat Res 416: 67-84
5. Breslow NE, Day NE (1980) The analysis of case-control studies. In: Davis W (eds) Statistical methods in cancer research vol 1. IARC Scientific Publication 32. IARC, Lyon
6. Buchet JP, Gennart JP, Mercado-Calderon F, Delavignette JP, Cupers L, Lauwerys R (1992) Evaluation of exposure to polycyclic aromatic hydrocarbons in a coke production and a graphite electrode manufacturing plant: assessment of urinary excretion of 1-hydroxypyrene as a biological indicator of exposure. Br J Ind Med 49: 761-768
7. Butkiewicz D, Grzybowska E, Hemminki K, Ovrebo S, Haugen A, Motykiewicz G, Chorazy M (1998) Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP IA1, CYP 2D6 and GSTM1 genetic polymorphisms. Mutat Res 414: 97-108
8. Caravanos J (1991) Quantitative industrial hygiene: a formula workbook. American Conference of Governmental Industrial Hygenists, Cincinnati, Ohio
9. Cascorbi I, Brockmoller J, Roots I (1996) A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 56: 4965-4969
10. Celotti L, Viezzer C, Pavanello S, Ferraro P, Levis AG, Ferri G, Foa' V (1996) DNA adduct levels in peripheral blood lymphocytes of coke-oven workers. J Clean Technol Environ Toxicol Occup Med 5: 167-177
11. Clonfero E, Granella M, Marchioro M, Leopardi-Barra E, Nardini B, Ferri G, Foa' V (1995) Urinary mutagens in coke oven workers. Carcinogenesis 16: 547-554
12. Dell'Omo M, Muzi G, Marchionna G, Latini L, Carrieri P, Paolemili P, Abbritti G (1998) Preventive measures reduce exposure to polycyclic aromatic hydrocarbons at a graphite electrode plant. Occup Environ Med 55: 401-406
13. Denissenko MF, Pao A, Tang M, Pfeifer GP (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274: 430-432
14. D'Errico A, Taioli E, Chen X, Vineis P (1996) Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers 1: 149-173
15. Dipple A, Moschel RC, Bigger CAH (1984) Polynuclear aromatic hydrocarbons. In: Searle CE (ed) Chemical carcinogens, 2nd edn, vol 1. American Chemical Society, Washington, D.C., pp 141-163
16. Dixon WJ(1992) BMDP Statistical software manual. University of California, Berkeley
17. Ferreira M Jr, Buchet JP, Burrion JB, Moro J, Cupers L, Delavignette JP, Jacques J, Lauwerys R (1994) Determinants of urinary thioethers, D-glucaric acid and mutagenicity after exposure to polycyclic aromatic hydrocarbons assessed by air monitoring and measurement of 1-hydroxypyrene in urine: a cross-sectional study in workers of coke and graphite-electrode-producing plants. Int Arch Occup Environ Health 65: 329-338
18. Gabbani G, Hou S-M, Nardini B, Marchioro M, Lambert B, Clonfero E (1996) GSTMI and NAT2 genotypes and urinary mutagens in coke oven workers Carcinogenesis 17: 1677-1681
19. Gelboin HV (1980) Benzo[a]pyrene metabolism, activation, and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 60: 1107-1166
20. Godschalk RWL, Ostertag JU, Moonen, EJC, Neumann HAM, Kleinjans JCS, Van Schooten FJ (1998) Aromatic DNA adducts in human white blood cells and skin after dermal application of coal tar. Cancer Epidemiol Biomarkers Prev 7: 767-773
21. Grinberg-Funes RA, Singh VN, Perera FP, Bell DA, Young TL, Dickey C, Wang LW, Santella RM (1994) Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione S-transferase M1 genotypes. Carcinogenesis 15: 2449-2454
22. Hayes JD, Pulford DJ (1995) The glutathione S-transferase supergene family: regulation of GST * and the contribution of the isoezymes to cancer chemoprotection and drugs. Crit Rev Biochem Mol Biol 30: 445-600
23. Hemminki K, Grzybowska E, Chorazy M, Twardowska-Saucha K, Sroczynsky JW, Putman KL, Randerath K, Phillips DH, Hewer A, Santella RM, Young TL, Perera FP (1990) DNA adducts in humans environmentally exposed to aromatic compounds in an industrial area in Poland. Carcinogenesis 11: 1229-1231
24. Hemminki K, Yang K, Rajaniemi H, Tyndyk M, Lichachev A (1997) Postlabeling-HPLC analysis of lipophilic DNA adducts from human lung. Biomarkers 2: 341-347
25. Hou S-M, Lambert B, Hemminki K (1995) Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis 16: 1913-1917
26. Ichiba M, Hagmar L, Rannung A, Hogstedt B, Alexandrie AK, Carstensen U, Hemminki K (1994) Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GSTM1 in chimney sweeps. Carcinogenesis 15: 1347-1352
27. International Agency for Research on Cancer (IARC) (1983) Polynuclear aromatic compounds. 1. Chemical, environment and experimental data. IARC monographs, vol 32. IARC, Lyon
28. International Agency for Research on Cancer (IARC) (1984) Polynuclear aromatic compounds. 3. Industrial exposures in aluminum production, coal gasification, coke production, and iron and steel founding. IARC monographs, vol 34. IARC, Lyon
29. Johns MB, Paulus-Thomas JE (1989) Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol. Anal Biochem 180: 276-278
30. Jongeneelen FJ, Anzion RBM, Henderson PT (1987) Determination of hydroxylated metabolites of polycyclic aromatic hydrocarbons in urine. J Chromatogr 413: 227-232
31. Jongeneelen FJ, Van Leeuwen FE, Oosterink S, Anzion RBM, Van der Loop F, Bos RP, Van Veen HG (1990) Ambient and biological monitoring of coke oven workers: determinants of the internal dose of polycyclic aromatic hydrocarbons. Br J Ind Med 47: 454-461
32. Kawajiry K, Eguchi H, Nakachi K, Sekiya T, Yamamoto M (1996) Association of CYP 1A1 germline polymorphism with mutations of the p53 gene in lung cancer. Cancer Res 56: 72-76
33. Ketterer B (1996) Effect of genetic polymorphism and enzyme induction in the glutathione S-transferase family on chemical safety and risk assessment. Environ Toxicol Pharmacol 2: 157-160
34. Kriek E, Rojas M, Alexandrov K, Bartsch H (1998) Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutat Res 400: 215-231
35. McWilliams JE, Sanderson BJS, Harris EL, Richer-Boe KE, Henner WD (1995) Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 4: 589-594
36. Mooney LA, Bell DA, Santella RM, Van Bennekum AM, Ottman R, Paik M, Blaner WS, Lucier GW, Coney L, Young TL (1997) Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis 18: 503-509
37. Nielsen PS, Okkels H, Sigsgaard T, Kyrtopoulos S, Autrup H (1996a) Exposure to urban and rural air pollution: DNA and protein adducts and effect of glutathione-S-transferase genotype on adduct levels. Int Arch Occup Environ Health 68: 170-176
38. Nielsen PS, De Pater N, Okkels H, Autrup H (1996b) Environmental air pollution and DNA adducts in Copenhagen bus drivers. Effect of GSTM1 and NAT2 genotypes on adduct levels. Carcinogenesis 17: 1021-1027
39. Ovrebo S, Hangen A, Fjeldstad PE, Hemminki K, Szyfter K (1994) Biological monitoring of exposure to polycyclic aromatic hydrocarbons in an electrode paste plant. J Occup Med 36: 303-310
40. Pavanello S, Rojas M, Paleologo M, Levis AG, Alexandrov K (1989) Evidence for substantial formation of r7, t-8-dihydroxy-c-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene-deoxyguanosine in human lymphocytes treated in vitro with benzo[a]pyrene. Carcinogenesis 10: 945-947
41. Pavanello S, Zanesi N, Levis AG (1992) BaP metabolism and DNA adduct formation in cultured human lymphocytes treated in vitro with BaP and BaP-7,8-dihydrodiol. ATLA 20: 126-137
42. Pavanello S, Favretto D, Brugnone F, Mastrangelo G, Dal Pra G. Clonfero E (1999) HPLC/fluorescence determination of anti-BPDE-DNA adducts in mononuclear white blood cells from PAH-exposed humans. Carcinogenesis 20: 431-435
43. Perera FP (1997) Environment and cancer: who are susceptible? Science 278: 1068-1073
44. Popp W, Vahrenholz C, Schell C, Grimmer G, Dettbarn G, Kraus R, Brauksiepe A, Schmeling B, Gutzeit T, Von Blow J, Norpoth K (1997) DNA single strand breakage, DNA adducts, and sister chromatid exchange in lymphocytes and phenanthrene and pyrene metabolites in urine of coke oven workers. Occup Environ Med 54: 176-183
45. Robertson IGC, Guthenberg G, Mannervik B, Jernström B (1986) Differences in stereoselectivity and catalytic efficiency of three human glutathione transferases in the conjugation of glutathione with 7β,8-dihydroxy-9,10-oxy-7,8,9,10-tetrahydro-benzo[a]pyrene. Cancer Res 46: 2220-2224
46. 32P-postlabeling and ELISA. Carcinogenesis 15: 557-560
47. Rojas M, Alexandrov K, Aubertin G, Wastiaux-Denamur A, Mayer L, Mahieu B, Sebastien P, Bartsch H (1995) anti-Benzo[a]pyrene diolepoxide-DNA adduct levels in peripheral mononuclear cells from coke oven workers and the enhancing effect of smoking. Carcinogenesis 16: 1373-1376
48. Rojas M, Alexandrov K, Cascorbi I, Brockmöller J, Likhachev A, Pozharisski K, Bouvier G, Auburtin G, Mayer L, KoppSchneider A, Roots I, Bartsch H (1998) High benzo(a)pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MspI-GSTM1 *0 *0 genotypes. Pharmacogenetics 8: 109-118
49. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Ogrid D, Ulvik A, Vu P, Haugen A (1997) Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18: 1285-1289
50. Santella RM, Hemminki K, Tang DL, Paik M, Ottman R, Young TL, Savela K, Vodika L, Dickey C, Whyatt R, Perera FP (1993) Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells and 1-hydroxypyrene in foundry workers. Cancer Epidemiol Biomarkers Prev 2: 59-62
51. Santella RM, Perera FP, Young TL, Zhang YJ, Chiamprasert S, Tang DL, Wang LW, Beachman A, Lin JH, DeLeo VA (1995) Polycyclic aromatic hydrocarbon-DNA and protein adducts in coal tar treated patients and controls and their relationship to glutathione S-transferase genotype. Mutat Res 334: 117-124
52. Seidegård J, Pero RW, Markowitz MM, Roush G, Beattie EJ (1990) Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis 11: 33-36
53. Sram RJ (1998) Effect of glutathione S-transferase M1 polymorphisms on biomarkers of exposure and effects. Environ Health Perspect 106: 231-239
54. Van Hummelen P, Gennart JP, Buchet JP, Lauwerys R, Kirsch-Volders M (1993) Biological markers in PAH exposed workers and controls. Mutat Res 300: 231-239
55. Van Schooten FJ, Van Leeuwen FE, Hillebrand MJX, De Rijke ME, Hart AAM, Van Veen HG, Oosterink S, Kriek E (1990) Determination of benzo(a)pyrene diol epoxide-DNA adducts in white blood cell DNA from coke-oven workers: the impact of smoking. J Natl Cancer Inst 82: 927-933
56. Van Schooten FJ, Jongeneelen FJ, Hillebrand MJX, Van Leeuwen FE, De Loof AJA, Dijkmans APG, Van Rooij JGM, Den Engelse L, Kriek E (1995) Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells and 1-hydroxypyrene in the urine from aluminum workers: relation with job category and synergistic effect of smoking. Cancer Epidemiol Biomarkers Prev 4: 69-77
57. Vaury C, Lainé R, Noguiez P, De Coppet P, Jaulin C, Praz F, Pompon D, Amor-Guéret M (1995) Human glutathione S-transferase M1 null genotype is associated with a high inducibility of cytochrome P450 1A1 gene transcription. Cancer Res 55: 5520-5523